Stem Cell Research (Dec 2023)

Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disease harboring the recurrent intronic ABCA4 variant c.4253+43G>A

  • Nuria Suárez-Herrera,
  • Nico Leijsten,
  • Silvia Albert,
  • Nathalie M. Bax,
  • Carel B. Hoyng,
  • Frans P.M. Cremers,
  • Alejandro Garanto,
  • Rob W.J. Collin

Journal volume & issue
Vol. 73
p. 103252

Abstract

Read online

Pathogenic variants in ABCA4 are associated with Stargardt disease (STGD1), an autosomal recessive macular dystrophy characterized by bilateral central vision loss due to a progressive degeneration of retinal cells. An induced pluripotent stem cell (iPSC) line was generated from late-onset STGD1 patient-derived fibroblasts harboring bi-allelic ABCA4 variants by lentivirus-induced reprogramming. The obtained iPSC line (RMCGENi020-A) showed pluripotent features after the reprogramming process. The generation of this iPSC line facilitates its use to differentiate it into relevant retinal-like cell models, with the aim to adequately evaluate the effects of the ABCA4 variants.